List of medications seeing major price changes in 2026
A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of…
This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious Income
Pfizer (NYSE: PFE) is one of the world’s largest and most respected pharmaceutical companies. That is an important…
Is Pfizer Stock an Underrated Healthcare Investment Play?
Pharmaceutical giant Pfizer (NYSE: PFE) recently had to drop its internally developed GLP-1 weight loss drug candidate. The…
Pfizer Bets On Monthly GLP-1 Obesity Drug To Reshape Growth Story
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
Japan’s Shionogi boosts ViiV stake in $2.13 billion deal as Pfizer exits
Jan 20 (Reuters) – Japan’s Shionogi & Co said on Tuesday it would pay $2.13 billion for new…
Bayer’s Monsanto sues Pfizer, BioNTech and Moderna over mRNA technology
Bayer’s Monsanto has sued COVID vaccine makers Pfizer, BioNTech and Moderna, for allegedly misusing its messenger RNA (mRNA)…
Should You Buy Pfizer While It’s Under $30?
Pfizer has been struggling for several years. The company’s pipeline could help it turn things around. It also…
Better Buy in 2026: Pfizer or Eli Lilly?
Eli Lilly has been a dominant force in the GLP-1 market, and that looks set to continue. Pfizer’s…
Pfizer, YaoPharma sign $150M GLP-1 obesity drug collaboration
Key Terms phase 1 medical Phase 1 is the first stage of testing…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
2 No-Brainer Healthcare Stocks to Buy Now
Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…